US Stock MarketDetailed Quotes

JAGX Jaguar Health

Watchlist
  • 1.0400
  • +0.0449+4.51%
Close Nov 29 13:00 ET
  • 1.0400
  • 0.00000.00%
Post 17:02 ET
12.27MMarket Cap-287P/E (TTM)

Jaguar Health Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
6.61%-6.34M
9.78%-8.17M
29.14%-7.05M
-0.42%-33.24M
-16.00%-7.45M
20.39%-6.79M
13.40%-9.06M
-29.24%-9.95M
5.34%-33.1M
28.02%-6.42M
Net income from continuing operations
-27.52%-10.19M
19.71%-9.72M
27.54%-9.15M
14.68%-41.87M
-2.63%-9.15M
36.66%-7.99M
-28.95%-12.11M
30.47%-12.63M
6.70%-49.08M
37.76%-8.91M
Operating gains losses
100.87%32K
400.00%30K
-4,064.52%-1.23M
-266.71%-3.65M
1,000.00%9K
-369,300.00%-3.69M
100.96%6K
-98.90%31K
-10.22%2.19M
---1K
Depreciation and amortization
-4.64%596K
-9.98%559K
10.71%610K
4.19%2.39M
-1.83%591K
6.47%625K
-4.17%621K
21.10%551K
26.42%2.29M
25.94%602K
Other non cash items
--0
-99.71%9K
-81.00%274K
6.33%13.38M
-45.31%1.72M
124.06%7.09M
10.36%3.13M
-58.12%1.44M
142.55%12.58M
103.90%3.14M
Change In working capital
96.82%-178K
37.91%-1.24M
14.53%-153K
-150.65%-11.1M
-43.51%-3.33M
-2,221.58%-5.6M
53.86%-2M
-107.28%-179K
-295.32%-4.43M
-220.59%-2.32M
-Change in receivables
121.62%64K
411.61%349K
-54.85%465K
170.78%298K
-1,145.16%-324K
28.16%-296K
-168.71%-112K
607.39%1.03M
-117.43%-421K
-49.18%31K
-Change in inventory
-2.61%-118K
-227.62%-536K
110.18%169K
-1.93%-2.17M
-91.49%-810K
-179.86%-115K
122.50%420K
-7,645.45%-1.66M
-0.28%-2.12M
-9.30%-423K
-Change in prepaid assets
-17.64%962K
57.86%-1.53M
-610.00%-1.14M
-221.22%-5.01M
-668.81%-2.39M
2,079.66%1.17M
-113.79%-3.63M
-131.56%-160K
-95.98%-1.56M
-154.28%-311K
-Change in payables and accrued expense
102.30%143K
-56.48%628K
-265.54%-1.13M
-802.95%-3.81M
112.22%288K
-2,475.19%-6.22M
207.68%1.44M
-68.54%682K
-83.02%542K
-208.32%-2.36M
-Change in other current assets
-26,575.00%-1.07M
-50.00%1K
4,183.33%735K
96.91%-17K
-99.64%3K
95.51%-4K
100.15%2K
-260.00%-18K
-34.80%-550K
289.89%845K
-Change in other current liabilities
4.80%-119K
9.02%-111K
-101.89%-107K
-25.08%-394K
9.62%-94K
-43.68%-125K
-28.42%-122K
-82.76%-53K
-1,557.89%-315K
-89.09%-104K
-Change in other working capital
---43K
---42K
--850K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
6.61%-6.34M
9.78%-8.17M
29.14%-7.05M
-0.42%-33.24M
-16.00%-7.45M
20.39%-6.79M
13.40%-9.06M
-29.24%-9.95M
5.34%-33.1M
28.02%-6.42M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
-27,816.67%-1.68M
-103.45%-361K
Net PPE purchase and sale
--0
----
----
--0
--0
--0
----
----
-1,183.33%-77K
--0
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
---1.6M
---361K
Cash from discontinued investing activities
Investing cash flow
--0
----
----
--0
--0
--0
----
----
-27,816.67%-1.68M
-103.45%-361K
Financing cash flow
Cash flow from continuing financing activities
150.53%3.53M
274.56%12.57M
-34.78%12.27M
47.65%34.23M
550.18%10.65M
-86.11%1.41M
3.42%3.36M
130.81%18.81M
-47.24%23.18M
-47.52%1.64M
Net issuance payments of debt
-26.28%216K
-64.91%-94K
22.38%-222K
-102.58%-100K
-377.78%-50K
-92.50%293K
-107.79%-57K
63.43%-286K
-57.20%3.88M
-96.94%18K
Net common stock issuance
162.49%3.75M
715.71%12.67M
-30.09%12.49M
56.88%32.1M
320.52%11.25M
-77.03%1.43M
-36.72%1.55M
96.10%17.87M
-39.06%20.46M
-17.15%2.68M
Net preferred stock issuance
--0
----
----
--611K
--0
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
----
----
--1.24M
--1K
--0
----
----
--0
--0
Net other financing activities
----
----
----
132.87%380K
47.54%-554K
-1,838.89%-313K
-75.00%15K
792.13%1.23M
-58.14%-1.16M
-51.72%-1.06M
Cash from discontinued financing activities
Financing cash flow
150.53%3.53M
274.56%12.57M
-34.78%12.27M
47.65%34.23M
550.18%10.65M
-86.11%1.41M
3.42%3.36M
130.81%18.81M
-47.24%23.18M
-47.52%1.64M
Net cash flow
Beginning cash position
86.03%16.05M
-18.77%11.67M
18.28%6.47M
-67.93%5.47M
-69.45%3.23M
-4.29%8.63M
-17.70%14.37M
-67.93%5.47M
110.77%17.05M
-14.66%10.56M
Current changes in cash
47.76%-2.81M
177.00%4.39M
-41.11%5.22M
108.49%985K
162.16%3.2M
-444.49%-5.38M
32.71%-5.7M
1,848.57%8.87M
-229.43%-11.6M
-210.05%-5.15M
Effect of exchange rate changes
255.00%31K
75.61%-10K
-159.38%-19K
-6.25%15K
-18.52%44K
-33.33%-20K
-251.85%-41K
164.00%32K
--16K
--54K
End cash Position
311.31%13.27M
86.03%16.05M
-18.77%11.67M
18.28%6.47M
18.28%6.47M
-69.45%3.23M
-4.29%8.63M
-17.70%14.37M
-67.93%5.47M
-67.93%5.47M
Free cash flow
6.61%-6.34M
9.61%-8.19M
29.14%-7.05M
4.42%-33.24M
-9.83%-7.45M
20.91%-6.79M
22.70%-9.06M
-29.24%-9.95M
0.56%-34.78M
23.97%-6.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 6.61%-6.34M9.78%-8.17M29.14%-7.05M-0.42%-33.24M-16.00%-7.45M20.39%-6.79M13.40%-9.06M-29.24%-9.95M5.34%-33.1M28.02%-6.42M
Net income from continuing operations -27.52%-10.19M19.71%-9.72M27.54%-9.15M14.68%-41.87M-2.63%-9.15M36.66%-7.99M-28.95%-12.11M30.47%-12.63M6.70%-49.08M37.76%-8.91M
Operating gains losses 100.87%32K400.00%30K-4,064.52%-1.23M-266.71%-3.65M1,000.00%9K-369,300.00%-3.69M100.96%6K-98.90%31K-10.22%2.19M---1K
Depreciation and amortization -4.64%596K-9.98%559K10.71%610K4.19%2.39M-1.83%591K6.47%625K-4.17%621K21.10%551K26.42%2.29M25.94%602K
Other non cash items --0-99.71%9K-81.00%274K6.33%13.38M-45.31%1.72M124.06%7.09M10.36%3.13M-58.12%1.44M142.55%12.58M103.90%3.14M
Change In working capital 96.82%-178K37.91%-1.24M14.53%-153K-150.65%-11.1M-43.51%-3.33M-2,221.58%-5.6M53.86%-2M-107.28%-179K-295.32%-4.43M-220.59%-2.32M
-Change in receivables 121.62%64K411.61%349K-54.85%465K170.78%298K-1,145.16%-324K28.16%-296K-168.71%-112K607.39%1.03M-117.43%-421K-49.18%31K
-Change in inventory -2.61%-118K-227.62%-536K110.18%169K-1.93%-2.17M-91.49%-810K-179.86%-115K122.50%420K-7,645.45%-1.66M-0.28%-2.12M-9.30%-423K
-Change in prepaid assets -17.64%962K57.86%-1.53M-610.00%-1.14M-221.22%-5.01M-668.81%-2.39M2,079.66%1.17M-113.79%-3.63M-131.56%-160K-95.98%-1.56M-154.28%-311K
-Change in payables and accrued expense 102.30%143K-56.48%628K-265.54%-1.13M-802.95%-3.81M112.22%288K-2,475.19%-6.22M207.68%1.44M-68.54%682K-83.02%542K-208.32%-2.36M
-Change in other current assets -26,575.00%-1.07M-50.00%1K4,183.33%735K96.91%-17K-99.64%3K95.51%-4K100.15%2K-260.00%-18K-34.80%-550K289.89%845K
-Change in other current liabilities 4.80%-119K9.02%-111K-101.89%-107K-25.08%-394K9.62%-94K-43.68%-125K-28.42%-122K-82.76%-53K-1,557.89%-315K-89.09%-104K
-Change in other working capital ---43K---42K--850K----------------------------
Cash from discontinued investing activities
Operating cash flow 6.61%-6.34M9.78%-8.17M29.14%-7.05M-0.42%-33.24M-16.00%-7.45M20.39%-6.79M13.40%-9.06M-29.24%-9.95M5.34%-33.1M28.02%-6.42M
Investing cash flow
Cash flow from continuing investing activities 0000-27,816.67%-1.68M-103.45%-361K
Net PPE purchase and sale --0----------0--0--0---------1,183.33%-77K--0
Net intangibles purchase and sale --------------0-------------------1.6M---361K
Cash from discontinued investing activities
Investing cash flow --0----------0--0--0---------27,816.67%-1.68M-103.45%-361K
Financing cash flow
Cash flow from continuing financing activities 150.53%3.53M274.56%12.57M-34.78%12.27M47.65%34.23M550.18%10.65M-86.11%1.41M3.42%3.36M130.81%18.81M-47.24%23.18M-47.52%1.64M
Net issuance payments of debt -26.28%216K-64.91%-94K22.38%-222K-102.58%-100K-377.78%-50K-92.50%293K-107.79%-57K63.43%-286K-57.20%3.88M-96.94%18K
Net common stock issuance 162.49%3.75M715.71%12.67M-30.09%12.49M56.88%32.1M320.52%11.25M-77.03%1.43M-36.72%1.55M96.10%17.87M-39.06%20.46M-17.15%2.68M
Net preferred stock issuance --0----------611K--0--0----------0--0
Proceeds from stock option exercised by employees --0----------1.24M--1K--0----------0--0
Net other financing activities ------------132.87%380K47.54%-554K-1,838.89%-313K-75.00%15K792.13%1.23M-58.14%-1.16M-51.72%-1.06M
Cash from discontinued financing activities
Financing cash flow 150.53%3.53M274.56%12.57M-34.78%12.27M47.65%34.23M550.18%10.65M-86.11%1.41M3.42%3.36M130.81%18.81M-47.24%23.18M-47.52%1.64M
Net cash flow
Beginning cash position 86.03%16.05M-18.77%11.67M18.28%6.47M-67.93%5.47M-69.45%3.23M-4.29%8.63M-17.70%14.37M-67.93%5.47M110.77%17.05M-14.66%10.56M
Current changes in cash 47.76%-2.81M177.00%4.39M-41.11%5.22M108.49%985K162.16%3.2M-444.49%-5.38M32.71%-5.7M1,848.57%8.87M-229.43%-11.6M-210.05%-5.15M
Effect of exchange rate changes 255.00%31K75.61%-10K-159.38%-19K-6.25%15K-18.52%44K-33.33%-20K-251.85%-41K164.00%32K--16K--54K
End cash Position 311.31%13.27M86.03%16.05M-18.77%11.67M18.28%6.47M18.28%6.47M-69.45%3.23M-4.29%8.63M-17.70%14.37M-67.93%5.47M-67.93%5.47M
Free cash flow 6.61%-6.34M9.61%-8.19M29.14%-7.05M4.42%-33.24M-9.83%-7.45M20.91%-6.79M22.70%-9.06M-29.24%-9.95M0.56%-34.78M23.97%-6.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data